Axonics Modulation Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Axonics Modulation Technologies, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include AXONICS, AXONICS MODULATION, and AXONICS SNM SYSTEM. The owner is based in Irvine, CA.
26 Technology Drive
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
Axonics Modulation Technologies, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Axonics Modulation Technologies, Inc. have?
Axonics Modulation Technologies, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned.
What trademark classes does Axonics Modulation Technologies, Inc. file in?
Axonics Modulation Technologies, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Axonics Modulation Technologies, Inc.'s most well-known trademarks?
Axonics Modulation Technologies, Inc.'s registered trademark portfolio includes well-known marks such as AXONICS, AXONICS MODULATION, and AXONICS SNM SYSTEM. These are among 3 currently registered trademarks in the portfolio.
What is Axonics Modulation Technologies, Inc.'s trademark registration success rate?
Axonics Modulation Technologies, Inc. has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.